Guideline Med Alerts & FDA Approvals – July 2024
A list of all the FDA approved medications in July 2024.
Read MoreA list of all the FDA approved medications in July 2024.
Read MoreA list of clinical practice guidelines and guideline summaries that were updated or published in July 2024.
Read MoreA list of all the FDA approved medications in June 2024.
Read MoreA list of clinical practice guidelines and guideline summaries that were updated or published in June 2024.
Read MoreBreyanzi (Bristol Myers Squibb)Expanded Indication Retevmo (Eli Lilly) Expanded Indication Onyda XR (Tris Pharma) Bkemv (Amgen)Biosimilar to Soliris Opuviz (Biogen) Biosimilar to Eylea Yesafili (Biocon Biologics) Biosimilar to Eylea Imdelltra (Amgen) Clinolipid (Baxter) Expanded Indication ColoSense (Geneoscopy) New Formulation Myhibbin (Azurity Pharmaceuticals) New Formulation Cyltezo (Boehringer Ingelheim) New Formulation Sign up for alerts and stay informed on […]
Read MoreSign up for alerts and stay informed on the latest published guidelines, FDA decisions, and more! Copyright © 2024 Guideline Central, All rights reserved.
Read MoreMissed out on the latest clinical practice guidelines? Here’s a list of all the guidelines and FDA drug approvals that were published during the last month.
Read MoreMissed out on the latest clinical practice guidelines? Here’s a list of all the guidelines and FDA drug approvals that were published during the last month.
Read MoreMissed out on the latest clinical practice guidelines? Here’s a list of all the guidelines and FDA drug approvals that were published during the last month.
Read MoreMissed out on the latest clinical practice guidelines? Here’s a list of all the guidelines and FDA drug approvals that were published during the last month.
Read More